Psychiatry

>

Latest News

NeuroStim Announces Single-Day TMS Protocol With High Remission Rates in Depression / image credit ©PATTARAWIT/stock.adobe.com
NeuroStim Announces Single-Day TMS Protocol With High Remission Rates in Depression

August 26th 2025

One-Day TMS condenses transcranial magnetic stimulation therapy treatment from a daily month-long process to 1 day, with rapid and durable results, NeuroStim says.

Risk of Major Depressive Disorder Spikes Following a Medical Diagnosis, Endures for Decades / image credit ©Justlight/stock.adobe.com
Risk of Major Depressive Disorder Spikes Following a Medical Diagnosis, Endures for Decades: New Data

August 20th 2025

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update / image credit UVA Health Anita Clayton, MD
Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update

August 18th 2025

Investigational Antidepressant BH-200 Shows Benefit in Phase 2b Trial for MDD / Image credit: ©Srdjan/AdobeStock
Investigational Antidepressant BH-200 Shows Benefit in Phase 2b Trial for MDD

August 6th 2025

Maternal Depression Found to Disrupt Emotional Responsiveness, Infant Care: Daily Dose / image credit: ©New Africa/AdobeStock
Maternal Depression Found to Disrupt Emotional Responsiveness, Infant Care: Daily Dose

July 31st 2025

Latest CME Events & Activities
<1
...
34567
© 2025 MJH Life Sciences

All rights reserved.